TxCell's IPO

TxCell raised a round of funding on April 14, 2014. Investors include Public.

TxCell is dedicated to the development of therapeutic products for severe chronic inflammatory and autoimmune diseases with hight unmet medical need including inflammatory bowel diseases, inflammatory…

Articles about TxCell's IPO: